<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vestich</journal-id><journal-title-group><journal-title xml:lang="ru">Известия Национальной академии наук Беларуси. Серия химических наук</journal-title><trans-title-group xml:lang="en"><trans-title>Proceedings of the National Academy of Sciences of Belarus, Chemical Series</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-8331</issn><issn pub-type="epub">2524-2342</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1561-8331-2018-54-3-305-313</article-id><article-id custom-type="elpub" pub-id-type="custom">vestich-337</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРГАНИЧЕСКАЯ ХИМИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORGANIC CHEMISTRY</subject></subj-group></article-categories><title-group><article-title>СИНТЕЗ НОВЫХ 6-N-ЗАМЕЩЕННЫХ ПУРИНОВЫХ НУКЛЕОЗИДОВ</article-title><trans-title-group xml:lang="en"><trans-title>SYNTHESIS OF NEW 6-N-SUBSTITUTED PURINE NUCLEOSIDES</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулак</surname><given-names>Т. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulak</surname><given-names>T. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кулак Тамара Ивановна – канд. хим. наук, вед. науч. сотрудник</p><p>ул. акад. В.Ф. Купревича, 5/2, 220141, Минск</p></bio><bio xml:lang="en"><p>Tamara I. Kulak – Ph. D. (Chemistry), Leading Researcher</p><p>5/2, Acad. V.F. Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">kulak@iboch.bas-net.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Янковская</surname><given-names>Д. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Yankovskaya</surname><given-names>D. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Янковская Дарья Владимировна – инженер-химик, НПЦ «ХимФармСинтез»</p><p>ул. акад. В.Ф. Купревича, 5/2, 220141, Минск</p></bio><bio xml:lang="en"><p>Darya V. Yankovskaya – Engineer-Chemist, Research and Experimental Production “ChemPharmSynthesis”</p><p>5/2, Acad. V.F. Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">dasha-jankovskaja@yandex.by</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Коноплич</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Konoplich</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Коноплич Алена Викторовна – химик-фармацевт, НПЦ «ХимФармСинтез»</p><p>ул. акад. В.Ф. Купревича, 5/2, 220141, Минск</p></bio><bio xml:lang="en"><p>Alena V. Konoplich – Chemist-Pharmacist, Research and Experimental Production “ChemPharmSynthesis”</p><p>5/2, Acad. V.F. Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">alena.konoplich96@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Буравская</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Buravskaya</surname><given-names>T. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Буравская Татьяна Николаевна – канд. хим. наук, ст. науч. сотрудник</p><p>ул. акад. В.Ф. Купревича, 5/2, 220141, Минск</p></bio><bio xml:lang="en"><p>Tatyana N. Buravskaya – Ph. D. (Chemistry), Senior Researcher, Research and Experimental Production “ChemPharmSynthesis”</p><p>5/2, Acad. V.F. Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">butani@tut.by</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Калиниченко</surname><given-names>Е. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Kalinichenko</surname><given-names>E. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Калиниченко Елена Николаевна – член-корр., д-р хим наук, зам. директора</p><p>ул. акад. В.Ф. Купревича, 5/2, 220141, Минск</p></bio><bio xml:lang="en"><p>Elena N. Kalinichenko – Corresponding Member, D. Sc. (Chemistry), Deputy Director</p><p>5/2, Acad. V.F. Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">kalinichenko@iboch.bas-net.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт биоорганической химии Национальной академии наук Беларуси</institution></aff><aff xml:lang="en"><institution>Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Институт биоорганической химии Национальной академии наук Беларуси, НПЦ «ХимФармСинтез»</institution></aff><aff xml:lang="en"><institution>Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>14</day><month>09</month><year>2018</year></pub-date><volume>54</volume><issue>3</issue><fpage>305</fpage><lpage>313</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Кулак Т.И., Янковская Д.В., Коноплич А.В., Буравская Т.Н., Калиниченко Е.Н., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Кулак Т.И., Янковская Д.В., Коноплич А.В., Буравская Т.Н., Калиниченко Е.Н.</copyright-holder><copyright-holder xml:lang="en">Kulak T.I., Yankovskaya D.V., Konoplich A.V., Buravskaya T.N., Kalinichenko E.N.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vestichem.belnauka.by/jour/article/view/337">https://vestichem.belnauka.by/jour/article/view/337</self-uri><abstract><p>Осуществлен синтез новых производных пуриновых нуклеозидов, содержащих в 6-положении гетерооснования остатки N,N-диэтилэтилендиамина или N-(2-аминоэтил)пирролидина. Разработанные условия проведения реакции аминирования ряда 6-Cl-производных О-ацетилированных пуриновых нуклеозидов и сопутствующих реакций дезацилирования ОН-групп углеводного фрагмента под действием N-этилдиизопропиламина или N-(2-аминоэтил)пирролидина позволили получить деблокированные 6-N-замещенные нуклеозиды в одну стадию с хорошими выходами.</p></abstract><trans-abstract xml:lang="en"><p>New derivatives of purine nucleosides containing the residues of N,N-diethylethylenediamine or N-(2-aminoethyl)pyrrolidine in 6-position of heterobase have been synthesized. The one-step preparation of 6-N-substituted nucleosides was performed in good yields by the amination of 6-Cl-derivatives of O-acetylated purine nucleosides and concomitant deacylation of OH-groups of a carbohydrate moiety with N,N-diethylethylenediamine or N-(2-aminoethyl)pyrrolidine.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пуриновые нуклеозиды</kwd><kwd>N</kwd><kwd>N-диэтилэтилендиамин</kwd><kwd>N-(2-аминоэтил)пирролидин</kwd><kwd>аминирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>purine nucleosides</kwd><kwd>N</kwd><kwd>N-diethylethylenediamine</kwd><kwd>N-(2-aminoethyl)pyrrolidine</kwd><kwd>amination</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Drenichev, M. S. Cytokinin nucleosides – natural compounds with a unique spectrum biological activities / M.S. Drenichev, V.E. Oslovsky, S.N. Mikhailov // Curr. Top. Med. Chem. – 2016. – Vol. 16, №23. – P. 2562-2576. https://doi. org/10.2174/1568026616666160414123717</mixed-citation><mixed-citation xml:lang="en">Drenichev M. S., Oslovsky V. E., Mikhailov S. N. Cytokinin nucleosides – natural compounds with a unique spectrum biological activities. Current Topics in Medicinal Chemistry, 2016, vol. 16, no. 23, pp. 2562–2576. https://doi.org/10.2174/156 8026616666160414123717</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rosemeyer, H. The chemodiversity of purine as a constituent of natural products / H. Rosemeyer // Chem. Biodivers. – 2004. – Vol. 1, №3. – P. 361–401. https://doi.org/10.1002/cbdv.200490033</mixed-citation><mixed-citation xml:lang="en">Rosemeyer H. The chemodiversity of purine as a constituent of natural products. Chemistry and Biodiversity, 2004, vol. 1, no. 3, pp. 361–401. https://doi.org/10.1002/cbdv.200490033</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Романов, Г.А. Как цитокинины действуют на клетку / Г.А. Романов // Физиология растений. – 2009. – Т. 56, №2. – С. 295–319.</mixed-citation><mixed-citation xml:lang="en">Romanov G. A. How do cytokinins affect the cell? Russian Journal of Plant Physiology, 2009, vol. 56, no. 2, pp. 268– 290. https://doi.org/10.1134/s1021443709020174</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Preparation, biological activity and endogenous occurrence of N6-benzyladenosines / K. Doležal [et al.] // Bioorg. Med. Chem. – 2007. – Vol. 15, №11. – P. 3737–3747. https://doi.org/10.1016/j.bmc.2007.03.038</mixed-citation><mixed-citation xml:lang="en">Doležal K., Popa I., Hauserová E., Spíchal L., Chakrabarty K., Novák O., Kryštof V., Voller J., Holub J., Strnad M. Preparation, biological activity and endogenous occurrence of N6-benzyladenosines. Bioorganic &amp; Medicinal Chemistry, 2007, vol. 15, no. 11, pp. 3737–3747. https://doi.org/10.1016/j.bmc.2007.03.038</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">The discovery and synthesis of highly potent, A2a receptor agonists / S.E. Keeling [et al.] // Bioorg. Med. Chem. Lett. – 2000. – Vol. 10, №4. – P. 403–406. https://doi.org/10.1016/s0960-894x(00)00017-2</mixed-citation><mixed-citation xml:lang="en">Keeling S. E., Albinson F. D., Ayres B. E., Butchers P. R., Chambers C. L., Cherry P. C., Ellis F., Ewan G. B., Gregson M., Knight J., Mills K., Ravenscroft P., Reynolds L. H., Sanjar S., Sheehan M. J. The discovery and synthesis of highly potent, A2a receptor agonists. Bioorganic &amp; Medicinal Chemistry Letters, 2000, vol. 10, no. 4, pp. 403–406. https:// doi.org/10.1016/s0960-894x(00)00017-2</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists / Е. Elzein [et al.] // Bioorg. Med. Chem. Lett. – 2007. – Vol. 17, №1. – Р. 161–166. https://doi.org/10.1016/j.bmcl.2006.09.065</mixed-citation><mixed-citation xml:lang="en">Elzein E., Kalla R., Li X., Perry T., Marquart T., Micklatcher M., Li Y., Wu Y., Zeng D., Zablocki J., N6-Cycloalkyl2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists, Bioorganic &amp; Medicinal Chemistry Letters, 2007, vol. 17, no. 1, pp. 161–166. https://doi.org/10.1016/j.bmcl.2006.09.065</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">5-C-Ethyltetrazolyl-N6-substituted adenosine and 2-chloroadenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists / R. Petrelli [et al.] // J. Med. Chem. – 2015. – Vol. 58, №5. – P. 2560–2566. https://doi.org/10.1021/acs.jmedchem.5b00074</mixed-citation><mixed-citation xml:lang="en">Petrelli R., Torquati I., Kachler S., Luongo L., Maione S., Franchetti P., Grifantini M., Novellino E., Laveccia A., Klotz K.-N., Cappellacci L. 5-C-Ethyltetrazolyl- N6-substituted adenosine and 2-chloroadenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. Journal of Medicinal Chemistry, 2015, vol. 58, no. 5, pp. 2560–2566. https://doi.org/10.1021/acs.jmedchem.5b00074</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Chemical modification of the plant isoprenoid cytokinin N6-isopentenyladenosine yields a selective inhibitor of human enterovirus EV 71 replication / V.I. Tararov [et al.] // Eur. J. Med. Chem. – 2015. – Vol. 90. – P. 406–413. https://doi. org/10.1016/j.ejmech.2014.11.048</mixed-citation><mixed-citation xml:lang="en">Tararov V. I., Tijsma A., Kolyachkina S. V., Oslovsky V. E., Neyts J., Drenichev M. S., Leyssen P., Mikhailov S. N. Chemical modification of the plant isoprenoid cytokinin N6-isopentenyladenosine yields a selective inhibitor of human enterovirus EV 71 replication. European Journal of Medicinal Chemistry, 2015, vol. 90, pp. 406–413. https://doi.org/10.1016/j. ejmech.2014.11.048</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Anticancer activity of natural cytokinins: a structure-activity relationship study / J. Voller [et al.] // Phytochemistry. – 2010. – Vol. 71, №11–12. – P. 1350–1359. https://doi.org/10.1016/j.phytochem.2010.04.018</mixed-citation><mixed-citation xml:lang="en">Voller J., Zatloukal M., Lenobel R., Doležal K., Bereš T., Kryštof V., Spichal L., Niemann P., Džubak P., Hajduch M., Strnad M. Anticancer activity of natural cytokinins: a structure-activity relationship study. Phytochemistry, 2010, vol. 71, no. 11–12, pp. 1350–1359. https://doi.org/10.1016/j.phytochem.2010.04.018</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Anti-malarial activity of N6-modified purine analogues / K. Too [et al.] // Bioorg. Med. Chem. – 2007. – Vol. 15, №16. – P. 5551–5562. https://doi.org/10.1016/j.bmc.2007.05.038</mixed-citation><mixed-citation xml:lang="en">Too K., Brown D. M., Bongard E., Yardley V., Vivas L., Loakes D. Anti-malarial activity of N6-modified purine analogues. Bioorganic &amp; Medicinal Chemistry, 2007, vol. 15, no. 16, pp. 5551–5562. https://doi.org/10.1016/j.bmc.2007.05.038</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents / Y.A. Kim [et al.] // Biochem. Pharmacol. – 2007. – Vol. 73, №10. – P. 1558–1572. https://doi. org/10.1016/j.bcp.2007.01.026</mixed-citation><mixed-citation xml:lang="en">Kim Y. A., Sharon A., Chu C. K., Rais R. H., Al Safarialani O. N., Naguib F. N. M., el Kouni M. H. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents. Biochemical Pharmacology, 2007, vol. 73, no. 10, pp. 1558–1572. https://doi.org/10.1016/j.bcp.2007.01.026</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N6-substituted adenosine / J.C. Bressi [et al.] // J. Med. Chem. – 2000. – Vol. 43, №22. – P. 4135–4150. https://doi.org/10.1021/jm000287a</mixed-citation><mixed-citation xml:lang="en">Bressi J. C., Choe J., Hough M. T., Buckner F. S., Van Voorhis W. C., Verlinde C. L. M. J., Hol W. G. J., Gelb M. H. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N6-substituted adenosine. Journal of Medicinal Chemistry, 2000, vol. 43, no. 22, pp. 4135–4150. https://doi. org/10.1021/jm000287a</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Fleysher, M.H. N6-Substituted adenosines: synthesis, biological activity, and some structure-activity relationships / M.H. Fleysher // J. Med. Chem. – 1972. – Vol. 15, №2. – P. 187–191. https://doi.org/10.1021/jm00272a015</mixed-citation><mixed-citation xml:lang="en">Fleysher M. H. N6-Substituted adenosines: synthesis, biological activity, and some structure-activity relationships. Journal of Medicinal Chemistry, 1972, vol. 15, no. 2, pp. 187–191. https://doi.org/10.1021/jm00272a015</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">6-N-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity / R. Ottria [et al.] // Bioorg. Med. Chem. – 2010. – Vol. 18, №23. – P. 8396–8402. https://doi.org/10.1016/j.bmc.2010.09.030</mixed-citation><mixed-citation xml:lang="en">Ottria R., Casati S., Baldoli E., Maier J. A. M., Ciuffreda P. 6-N-Alkyladenosines: synthesis and evaluation of in vitro anticancer activity. Bioorganic &amp; Medicinal Chemistry, 2010, vol. 18, no. 23, pp. 8396–8402. https://doi.org/10.1016/j. bmc.2010.09.030</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl) purine derivatives, which lead to senescence-induced cell death in liver cancer cells / M. Tuncbilek [et al.] // J. Med. Chem. – 2012. – Vol. 55, №7. – P. 3058–3065. https://doi.org/10.1021/jm3001532</mixed-citation><mixed-citation xml:lang="en">Tuncbilek M., Guven E. B., Onder T., Atalay R. C. Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl) purine derivatives, which lead to senescence-induced cell death in liver cancer cells. Journal of Medicinal Chemistry, 2012, vol. 55, no. 7, pp. 3058–3065. https://doi.org/10.1021/jm3001532</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bredereck, H. Über methylierte Nucleoside und Purine und ihre pharmakologischen Wirkungen, I. Mitteil.: Methylierung von Nucleosiden durch Diazomethan / H. Bredereck, A. Martini // Chem. Ber. – 1947. – Vol. 80, №5. – P. 401– 405. https://doi.org/10.1002/cber.19470800505</mixed-citation><mixed-citation xml:lang="en">Bredereck H., Martini A. Über methylierte Nucleoside und Purine und ihre pharmakologischen Wirkungen, I. Mitteil.: Methylierung von Nucleosiden durch Diazomethan. Chemische Berichte, 1947, vol. 80, no. 5, pp. 401–405. https:// doi.org/10.1002/cber.19470800505</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Ikehara, M. Studies of nucleosides and nucleotides. XXVI. Further studies on the chlorination of inosine derivatives with dimethylformamide – thionyl chloride complex / M. Ikehara, H. Uno // Chem. Pharm. Bull. – 1965. – Vol. 13, №2. – P. 221–223. https://doi.org/10.1248/cpb.13.221</mixed-citation><mixed-citation xml:lang="en">Ikehara M., Uno H. Studies of nucleosides and nucleotides. XXVI. Further studies on the chlorination of inosine derivatives with dimethylformamide – thionyl chloride complex. Chemical &amp; Pharmaceutical Bulletin, 1965, vol. 13, no. 2, pp. 221–223. https://doi.org/10.1248/cpb.13.221</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Robins, M. J. Nucleic acid related compounds. 33. Conversions of adenosine and guanosine to 2,6-dichloro, 2-amino6-chloro, and derived purine nucleosides / M.J. Robins, B. Uznanski // Can. J. Chem. – 1981. – Vol. 59, №. 17. – P. 2601–2607. https://doi.org/10.1139/v81-374</mixed-citation><mixed-citation xml:lang="en">Robins M. J., Uznanski B. Nucleic acid related compounds. 33. Conversions of adenosine and guanosine to 2,6-dichloro, 2-amino-6-chloro, and derived purine nucleosides. Canadian Journal of Chemistry, 1981, vol. 59, no. 17, pp. 2601– 2607. https://doi.org/10.1139/v81-374</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Alternative and improved synthesis of highly potent and selective A3 adenosine receptor agonists, Cl-IB-MECA and Thio-Cl-IB-MECA / X. Hou [et al.] // Arch. Pharm. Res. – 2007. – Vol. 30, №10. – P. 1205–1209. https://doi.org/10.1007/ bf02980260</mixed-citation><mixed-citation xml:lang="en">Hou X., Lee H. W., Tosh D. K., Zhao L. X., Jeong L. S. Alternative and improved synthesis of highly potent and selective A3 adenosine receptor agonists, Cl-IB-MECA and Thio-Cl-IB-MECA. Archives of Pharmacal Research, 2007, vol. 30, no. 10, pp. 1205–1209. https://doi.org/10.1007/bf02980260</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Dekker, C.A. Separation of nucleoside mixtures on Dowex-1 (OH– ) / C.A. Dekker // J. Amer. Chem. Soc. – 1965. – Vol. 87, №17. – P. 4027–4029. https://doi.org/10.1021/ja01095a073</mixed-citation><mixed-citation xml:lang="en">Dekker C. A. Separation of nucleoside mixtures on Dowex-1 (OH– ). Journal of the American Chemical Society, 1965, vol. 87, no. 17, pp. 4027–4029. https://doi.org/10.1021/ja01095a073</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Schaffer, H. J. Synthesis of potential anticancer agents. XIV. Ribosides of 2,6-disubstituted purines / H.J. Schaffer, H.J. Thomas // J. Amer. Chem. Soc. – 1958. – Vol. 80, №14. – P. 3738–3742. https://doi.org/10.1021/ja01547a068</mixed-citation><mixed-citation xml:lang="en">Schaffer H. J., Thomas H. J. Synthesis of potential anticancer agents. XIV. Ribosides of 2, 6-disubstituted purines. Journal of the American Chemical Society, 1958, vol. 80, no. 14, pp. 3738–3742. https://doi.org/10.1021/ja01547a068</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Fiorini, M.T. Solution-phase synthesis of 2,6,9-trisubstituted purines / M.T. Fiorini, C. Abell // Tetrahedron Lett. – 1998. – Vol. 39, №13. – P. 1827–1830. https://doi.org/10.1016/s0040-4039(98)00098-7</mixed-citation><mixed-citation xml:lang="en">Fiorini M. T., Abell C. Solution-phase synthesis of 2,6,9-trisubstituted purines. Tetrahedron Letters, 1998, vol. 39, no. 13, pp. 1827–1830. https://doi.org/10.1016/s0040-4039(98)00098-7</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor / M.P. Bosch [et al.] // J. Med. Chem. – 2004. – Vol. 47, №. 16. – P. 4041–4053. https://doi.org/10.1021/jm031143+</mixed-citation><mixed-citation xml:lang="en">Bosch M. P., Campos F., Niubó I., Rosell G., Díaz J. L., Brea J., Loza M. I., Guerrero A. Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor. Journal of Medicinal Chemistry, 2004, vol. 47, no. 16, pp. 4041–4053. https://doi.org/10.1021/jm031143+</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Mason, S.F. Purine studies. Part II. The ultra-violet absorption spectra of some mono- and poly-substituted purines / S.F. Mason // J. Chem. Soc. – 1954. – P. 2071–2081. https://doi.org/10.1039/jr9540002071</mixed-citation><mixed-citation xml:lang="en">Mason S. F. Purine studies. Part II. The ultra-violet absorption spectra of some mono- and poly-substituted purine. Journal of the Chemical Society, 1954, pp. 2071–2081. https://doi.org/10.1039/jr9540002071</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Synthesis of sugar-modified 2,6-diaminopurine and guanine nucleosides from guanosine via transformation of 2-aminoadenosine and enzymatic deamination with adenosine deaminase / M.J. Robins [et al.] // Can. J. Chem. – 1997. – Vol. 75, №6. – P. 762–767. https://doi.org/10.1139/v97-092</mixed-citation><mixed-citation xml:lang="en">Robins M. J., Zou R., Hansske F., Wnuk S. F. Synthesis of sugar-modified 2,6-diaminopurine and guanine nucleosides from guanosine via transformation of 2-aminoadenosine and enzymatic deamination with adenosine deaminase. Canadian Journal of Chemistry, 1997, vol. 75, no. 6, pp. 762–767. https://doi.org/10.1139/v97-092</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
